Skip to main content

Table 1 Baseline population characteristics according to the baseline level of exposure to anticholinergic and sedative drugs

From: Impact of cumulative exposure to anticholinergic and sedative drugs on cognition in older adults: a memory clinic cohort study

Baseline DBI level:

No exposure

n = 314

Moderate exposure

n = 1339

High exposure

n = 317

 

Total

n = 1970

 

n (%) or mean ± sd

p-value

n (%) or mean ± sd

Sex

     

 Female

179 (57.0)

814 (60.8)

202 (63.7)

0.222

1195 (60.7)

Age (years)

79.8 ± 7.9

79.8 ± 7.1

78.8 ± 7.4

0.076

79.6 ± 7.3

Educational level n = 1,862

   

0.001

 

 None

46 (15.3)

191 (15.1)

68 (22.8)

 

305 (15.5)

 Primary

79 (26.2)

414 (32.8)

94 (31.5)

 

587 (29.8)

 Secondary and further

176 (58.5)

658 (52.1)

136 (45.6)

 

970 (49.3)

IADL (/8) n = 1,927

4.8 ± 2.3

4.5 ± 2.4

4.0 ± 2.4

 < 0.001

4.5 ± 2.4

NPI (/144) n = 1,522

16.2 ± 15.0

19.9 ± 16.1

23.8 ± 19.1

 < 0.001

20.0 ± 16.6

Anxiety disorders n = 1,887

5 (1.7)

27 (2.1)

7 (2.3)

0.851

39 (2.0)

Depressive disorders n = 1,887

4 (1.3)

32 (2.5)

21 (7.0)

 < 0.001

57 (2.9)

MMSE (/30)

21.6 ± 5.5

21.1 ± 5.6

20.5 ± 5.9

0.037

21.1 ± 5.7

  1. DBI Drug Burden Index, IADL Instrumental Activities of Daily Living score, MMSE Mini Mental State Examination, NPI Neuropsychiatric Inventory score